Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a ful l
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02583165” into the
“Other Terms” search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6150C00001” into the search box, and click “Find a Study”.
Full study title: A Phase 1 Study of MEDI1873 (GITR Agonist) in Adult Subjects
With Select Advanced Solid Tumors
National Clinical Trials number: NCT02583165
MedImmune Protocol Number: D6150C00001
MedImmune LLC, a wholly owned subsidiary of AstraZeneca, sponsored this
study and has its headquarters in Gaithersburg, Maryland, USA
The phone number for the AstraZeneca Information Center is +1-877-240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP)
is a non-profit organization focused on educating and informing the public about
clinical research participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100
Boston, MA 02109
1-877-MED-HERO
10
Version 1.0 2020_11_09